GABAA-receptor subtypes: A new pharmacology

Current Opinion in Pharmacology

Volumn 1, Issue 1, 2001, Pages 22-25

  Möhler, Hanns ^a   Crestani, Florence ^a   Rudolph, Uwe ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anxiety; Anxiolysis; Benzodiazepines; GABAA receptor; Knock in mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CENTRAL MUSCLE RELAXANT; HYPNOTIC SEDATIVE AGENT;

AMNESIA; ANIMAL; BINDING SITE; DRUG EFFECT; HUMAN; REVIEW; SEIZURE;

AMNESIA; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BINDING SITES; HUMANS; HYPNOTICS AND SEDATIVES; MUSCLE RELAXANTS, CENTRAL; RECEPTORS, GABA-A; SEIZURES;

EID: 0035260308     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00008-X     Document Type: Review

References (27)

1. Linn C, Reppert M. GABA synchronises clock cells within the suprachiasmatic circadian clock. Neuron. 25:2000;123-128.
2. A-receptor β3-subunit knockout mice GABA-mediated inhibition is nearly abolished in reticular nucleus, but not in relay cells in the thalamus. In these mice, the oscillatory synchrony in thalamocortical circuits was dramatically intensified, indicating that recurrent inhibitory connections within the reticular nucleus act as desynchronizers.
3. Buonomano DV, Merzenich MM. Temporal transformation transformed into a spacial code by a neural network with realistic property. Science. 267:1995;1028-1030.
4. Buonomano DV, Merzenich MM. Cortical plasticity: from synapses to maps. Annu Rev Neurosci. 21:1998;149-186.
5. Hensch TK, Fagiolini M, Mataga N, Stryker MP, Baekkeskov S, Kash SF. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science. 282:1998;1504-1508.
6. Fagiolini M, Hensch TK. Inhibitory threshold for critical-period activation in primary visual cortex. Nature. 404:2000;183-186. This paper provides evidence that a threshold level of inhibition within the visual cortex may trigger an experience-dependent critical peroid for circuit consolidation.
7. A receptors is essential for benzodiazepine agonist binding. J Biol Chem. 267:1992;1426-1429.
8. Kleingoor C, Wieland HA, Korpi ER, Seeburg PH, Kettenmann H. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. Neuroreport. 4:1993;187-190.
9. Benson JA, Löw K, Keist R, Mohler H, Rudolph U. Pharmacology of recombinant γ-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett. 431:1998;400-404.
10. 1.
11. A-receptors. Thus, for the first time, the molecular target for the anxiolytic action of benzodiazepine drugs was identified.
12. Crestani F, Martin JR, Möhler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol. 131:2000;1251-1254.
13. 2-subunit in situ. J Recept Res. 13:1993;467-477.
14. Nusser Z, Sieghart W, Benke D, Fritschy JM, Somogyi P. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor α subunits on hippocampal pyramidal cells. Proc Natl Acad Sci USA. 93:1996;11939-11944.
15. A receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol. 390:1998;194-210.
16. Bohlhalter S, Weinmann O, Möhler H, Fritschy JM. Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci. 16:1996;283-297.
17. 1(H101R) mice is reported. The sedative action of diazepam was blunted in the mutant mice, while the myorelaxant action of diazepam was unaffected. It is not reported whether the anxiolytic action of diazepam or L-838,417 was preserved in these mice.
18. A receptor. Eur Neuropsychopharmacol. 2:1992;232-234.
19. A receptor subtypes. In: Anxiolytic β-carbolines. Psychopharmacology Series (Edited by Stephens DN). 11:1993;50-61.
20. Hood SD, Argyropoulos SV, Nutt DJ. Agents in development for anxiety disorders. Current status and future potential. CNS Drugs. 13:2000;421-431.
21. Allen D, Curran HV, Lader M. The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. Eur J Clin Pharmacol. 45:1993;313-320.
22. Sanger DJ, Morel E, Perrault G. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol. 313:1996;35-42.
23. A receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci Res Commun. 25:1999;139-148.
24. A receptor a subunits as a strategy for developing hypnoselective and anxioselective drugs. Int J Neuropsychopharmacol 2000, 3:S41.3.
25. Suzuki M, Uchiumi M, Murasaki M. A comparative study of the psychological effects of DN-2327, a partial benzodiazepine agonist, and alprazolam. Psychopharmacol. 121:1995;442-450.
26. A receptor ligand of dual functionality. Brain Res. 714:1996;165-168.
27. Tang AH, Franklin SR, Carter DB, Sethy VH, Needham LM, Jacobsen EJ, Von Voigtlander PF. Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptor. Psychopharmacol. 131:1997;255-263.